These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18694970)

  • 21. Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice.
    Zoja C; Locatelli M; Pagani C; Corna D; Zanchi C; Isermann B; Remuzzi G; Conway EM; Noris M
    J Immunol; 2012 Oct; 189(7):3661-8. PubMed ID: 22942429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
    Siegler RL; Obrig TG; Pysher TJ; Tesh VL; Denkers ND; Taylor FB
    Pediatr Nephrol; 2003 Feb; 18(2):92-6. PubMed ID: 12579394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model.
    Song L; Xiao Y; Li X; Huang Y; Meng G; Ren Z
    Front Immunol; 2020; 11():619096. PubMed ID: 33552083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of renal damage and tubular regeneration in pregnant and non-pregnant adult female rats inoculated with a sublethal dose of Shiga toxin 2.
    Fischer Sigel LK; Sánchez DS; Sacerdoti F; Zotta E; Silberstein C
    Microb Pathog; 2024 Jan; 186():106482. PubMed ID: 38086442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
    Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
    Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome.
    Gómez SA; Fernández GC; Vanzulli S; Dran G; Rubel C; Berki T; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2003 Feb; 131(2):217-24. PubMed ID: 12562380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.
    Sheoran A; Jeong KI; Mukherjee J; Wiffin A; Singh P; Tzipori S
    BMC Immunol; 2012 Jun; 13():27. PubMed ID: 22655967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of a product anti-Shiga toxin for prevention of the hemolytic uremic syndrome].
    Hiriart Y; Pardo R; Bukata L; Lauché C; Muñoz L; Colonna M; Goldbaum F; Sanguineti S; Zylberman V
    Medicina (B Aires); 2018; 78(2):107-112. PubMed ID: 29659360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.
    Dennhardt S; Pirschel W; Wissuwa B; Daniel C; Gunzer F; Lindig S; Medyukhina A; Kiehntopf M; Rudolph WW; Zipfel PF; Gunzer M; Figge MT; Amann K; Coldewey SM
    Front Immunol; 2018; 9():1459. PubMed ID: 29988557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ingested Shiga toxin 2 (Stx2) causes histopathological changes in kidney, spleen, and thymus tissues and mortality in mice.
    Rasooly R; Do PM; Griffey SM; Vilches-Moure JG; Friedman M
    J Agric Food Chem; 2010 Aug; 58(16):9281-6. PubMed ID: 20681531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects
    Luz D; Amaral MM; Sacerdoti F; Bernal AM; Quintilio W; Moro AM; Palermo MS; Ibarra C; Piazza RMF
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30513821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.
    Ramos MV; Auvynet C; Poupel L; Rodero M; Mejias MP; Panek CA; Vanzulli S; Combadiere C; Palermo M
    Am J Pathol; 2012 Mar; 180(3):1040-1048. PubMed ID: 22203055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.
    Tzipori S; Sheoran A; Akiyoshi D; Donohue-Rolfe A; Trachtman H
    Clin Microbiol Rev; 2004 Oct; 17(4):926-41, table of contents. PubMed ID: 15489355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosstalk between Human Microvascular Endothelial Cells and Tubular Epithelial Cells Modulates Pro-Inflammatory Responses Induced by Shiga Toxin Type 2 and Subtilase Cytotoxin.
    Álvarez RS; Jancic C; Garimano N; Sacerdoti F; Paton AW; Paton JC; Ibarra C; Amaral MM
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31703347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage.
    Landoni VI; Pittaluga JR; Carestia A; Castillo LA; Nebel MC; Martire-Greco D; Birnberg-Weiss F; Schattner M; Schierloh P; Fernández GC
    Front Cell Infect Microbiol; 2022; 12():897019. PubMed ID: 35811684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lepirudin prevents lethal effects of Shiga toxin in a canine model.
    Raife T; Friedman KD; Fenwick B
    Thromb Haemost; 2004 Aug; 92(2):387-93. PubMed ID: 15269836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome.
    Dran GI; Fernández GC; Rubel CJ; Bermejo E; Gomez S; Meiss R; Isturiz MA; Palermo MS
    Kidney Int; 2002 Oct; 62(4):1338-48. PubMed ID: 12234304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.